bioAffinity Technologies Balance Sheet Health
Financial Health criteria checks 6/6
bioAffinity Technologies has a total shareholder equity of $4.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.2M and $3.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.82m |
| Equity | US$4.86m |
| Total liabilities | US$3.37m |
| Total assets | US$8.22m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: BIAF's short term assets ($4.0M) exceed its short term liabilities ($2.2M).
Long Term Liabilities: BIAF's short term assets ($4.0M) exceed its long term liabilities ($1.1M).
Debt to Equity History and Analysis
Debt Level: BIAF is debt free.
Reducing Debt: BIAF had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIAF has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BIAF is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.